Facebook
Twitter
Telegram
Report an ErrorINmune Bio Balance Sheet 2011-2024 | INMB
Annual Balance Sheet INmune Bio
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-35.3 M | -42.4 M | -74 M | -21.8 M | -6.83 M | -186 K | -1.37 M | 208 K | - | - | - | - | - |
Long Term Debt |
397 K | 9.7 M | 704 K | - | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
119 K | 87 K | 72 K | 33.9 K | 8.29 K | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 126 K | 160 K | - | - | - | - | - | - | - | - |
Total Current Liabilities |
18.5 M | 10.9 M | 4.36 M | 1.78 M | 700 K | - | - | - | - | - | - | - | - |
Total Liabilities |
18.9 M | 21.7 M | 19.7 M | 1.9 M | 861 K | 824 K | 310 K | 601 K | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-121 M | -91 M | -63.7 M | -33.4 M | -21.3 M | -13.6 M | -1.16 M | -326 K | - | - | - | - | - |
Total Assets |
57 M | 81.8 M | 99.9 M | 40.7 M | 24.5 M | 17.4 M | 18.4 M | 452 K | - | - | - | - | - |
Cash and Cash Equivalents |
35.8 M | 52.2 M | 74.8 M | 22 M | 7 M | 186 K | 1.37 M | - | - | - | - | - | - |
Book Value |
38.1 M | 60.1 M | 80.2 M | 38.8 M | 23.6 M | 16.5 M | 18.1 M | -149 K | - | - | - | - | - |
Total Shareholders Equity |
37.3 M | 60.1 M | 80.2 M | 38.8 M | 23.6 M | 16.5 M | 18.1 M | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet INmune Bio
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
12.5 M | 15 M | 15 M | 526 K | 15 M | - | 15 M | 704 K | 15 M | 14.3 M | 116 K | 126 K | 126 K | 126 K | 126 K | 160 K | 160 K | 160 K | 160 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
18 M | 19.1 M | 18.7 M | 21.7 M | 20.1 M | - | 18.7 M | 19.7 M | 19.4 M | 17.5 M | 2.31 M | 1.9 M | 1.9 M | 1.9 M | 1.9 M | 861 K | 861 K | 861 K | 861 K | 824 K | 824 K | 824 K | 824 K | 310 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-113 M | -104 M | -97.6 M | -91 M | -85.2 M | - | -70.6 M | -63.7 M | -54 M | -44.6 M | -37.9 M | -33.4 M | -33.4 M | -33.4 M | -33.4 M | -21.3 M | -21.3 M | -21.3 M | -21.3 M | -13.6 M | -13.6 M | -13.6 M | -13.6 M | -1.16 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
62.7 M | 69.7 M | 74 M | 81.8 M | 83.8 M | - | 94.4 M | 99.9 M | 108 M | 60.7 M | 65.9 M | 40.7 M | 40.7 M | 40.7 M | 40.7 M | 24.5 M | 24.5 M | 24.5 M | 24.5 M | 17.4 M | 17.4 M | 17.4 M | 17.4 M | 18.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
41.8 M | 47.8 M | 51 M | 52.2 M | 57.4 M | 61.2 M | 66.7 M | 74.8 M | 84.5 M | 39.5 M | 45.3 M | 22 M | 22 M | 22 M | 22 M | 7 M | 7 M | 7 M | 7 M | 186 K | 186 K | 186 K | 186 K | 1.37 M | - | - | - | 142 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
44.7 M | 50.7 M | 55.3 M | 60.1 M | 63.7 M | - | 75.6 M | 80.2 M | 88.3 M | 43.2 M | 63.6 M | 38.8 M | 38.8 M | 38.8 M | 38.8 M | 23.6 M | 23.6 M | 23.6 M | 23.6 M | 16.5 M | 16.5 M | 16.5 M | 16.5 M | 18.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
43.9 M | 50.7 M | 55.3 M | 60.1 M | 63.7 M | 69.9 M | 75.6 M | 80.2 M | 88.3 M | 43.2 M | 63.6 M | 38.8 M | 38.8 M | 38.8 M | 38.8 M | 23.6 M | 23.6 M | 23.6 M | 23.6 M | 16.5 M | 16.5 M | 16.5 M | 16.5 M | 18.1 M | - | - | - | -149 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency